| Characteristic | Market share |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
November 2016
Japan
2010 to 2015
market size is based on the shipment value at manufacturers
*Forecast.
Research targets were domestic leading OTC manufacturers.
The source states, that the OTC market is calculated by totaling the shipment amounts of both OTC (including guidance-needed medicines, first, second, and third-category nonprescription drugs) and designated quasi drugs (items that became quasi drugs designated by Ministry of Health, Labour and
Welfare), such as health drinks sold at convenience stores, etc.
The source provides the following information: "The figures until 2011 are extracted from Statistics on Dynamic Pharmaceutical Industrial Production
from MHLW, the figures from 2012 to 2015 are based on prospects by Yano Research Institute, and the figures in 2016 and beyond are forecast calculated by Yano Research Institute."
Some values were rounded by the source, so that the ratio in the figure may not match.









